Atlas Trials

A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment.

Clinical trial NCT02679001 · COMPLETED

Trial details

NCT number
NCT02679001
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Study type
OBSERVATIONAL
Rheumatoid Arthritis
Start date
2016-03-24
Primary completion
2017-12-07
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.